1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Biomarcadores y Abordaje Personalizado del Cáncer (BioPAC)

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fernández-Argüeso M, Gómez-Bayona E, Ugalde B, Vega-Piñero B, Gil-Díaz M, Longo F, Pintor R, Botella-Carretero JI.

    Ready-to-Use Multichamber Bags in Home Parenteral Nutrition for Patients with Advanced Cancer: A Single-Center Prospective Study.

    Nutrients . 16(3): .

    [doi:10.3390/nu16030457]

  • Carrato A, Pazo-Cid R, Macarulla T, Gallego J, Jiménez-Fonseca P, Rivera F, Cano MT, Rodriguez-Garrote M, Pericay C, Alés I, Layos L, Graña B, Iranzo V, Gallego I, Garcia-Carbonero R, de Mena IR, Guillén-Ponce C, Aranda E.

    Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.

    Nejm Evidence . 3(2): .

    [doi:10.1056/EVIDoa2300144]

  • Alcalá S, Villarino L, Ruiz-Cañas L, Couceiro JR, Martínez-Calvo M, Palencia-Campos A, Navarro D, Cabezas-Sainz P, Rodriguez-Arabaolaza I, Cordero-Barreal A, Trilla-Fuertes L, Rubiolo JA, Batres-Ramos S, Vallespinos M, González-Páramos C, Rodríguez J, Gámez-Pozo A, Vara JÁF, Fernández SF, Berlinches AB, Moreno-Mata N, Redondo AMT, Carrato A, Hermann PC, Sánchez L, Torrente S, Fernández-Moreno MÁ, Mascareñas JL, Sainz B Jr.

    Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.

    Journal Of Experimental & Clinical Cancer Research . 43(1): 33-33.

    [doi:10.1186/s13046-023-02931-7]

  • Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C.

    A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma

    JOURNAL OF NEURO-ONCOLOGY . : .

    [doi:10.1007/s11060-023-04513-1]

  • Harrington KJ, Cohen EEW, Soulières D, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Swaby RF, Lin J, Ge J, Lerman N, Tourneau CL.

    Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

    ORAL ONCOLOGY . 147: 106587-106587.

    [doi:10.1016/j.oraloncology.2023.106587]

  • Zheng Q, Tang J, Aicher A, Bou Kheir T, Sabanovic B, Ananthanarayanan P, Reina C, Chen M, Gu JM, He B, Alcala S, Behrens D, Lawlo RT, Scarpa A, Hidalgo M, Sainz B Jr, Sancho P, Heeschen C.

    Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.

    Journal Of Experimental & Clinical Cancer Research . 42(1): 323-323.

    [doi:10.1186/s13046-023-02883-y]

  • Guerrero P, Albarrán V, San Román M, González-Merino C, García de Quevedo C, Moreno J, Calvo JC, González G, Orejana I, Chamorro J, Martínez-Delfrade Í, Morón B, de Frutos B, Ferreiro MR.

    BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

    Cancers . 15(21): .

    [doi:10.3390/cancers15215243]

  • Alors-Pérez E, Pedraza-Arevalo S, Blázquez-Encinas R, Moreno-Montilla MT, García-Vioque V, Berbel I, Luque RM, Sainz B Jr, Ibáñez-Costa A, Castaño JP.

    Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.

    Journal Of Experimental & Clinical Cancer Research . 42(1): 282-282.

    [doi:10.1186/s13046-023-02858-z]

  • Urbanova M, Cihova M, Buocikova V, Slopovsky J, Dubovan P, Pindak D, Tomas M, García-Bermejo L, Rodríguez-Garrote M, Earl J, Kohl Y, Kataki A, Dusinska M, Sainz B Jr, Smolkova B, Gabelova A.

    Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.

    BIOMEDICINE & PHARMACOTHERAPY . 165: 115179-115179. Nº de citas: 1

    [doi:10.1016/j.biopha.2023.115179]

  • Herrero JM, Fabra D, Matesanz AI, Hernández C, Sánchez-Pérez I, Quiroga AG.

    Dithiobiureas Palladium(II) complexes' studies: From their synthesis to their biological action.

    JOURNAL OF INORGANIC BIOCHEMISTRY . 246: 112261-112261.

    [doi:10.1016/j.jinorgbio.2023.112261]

  • Vaz-Salgado MA, Villamayor M, Albarrán V, Alía V, Sotoca P, Chamorro J, Rosero D, Barrill AM, Martín M, Fernandez E, Gutierrez JA, Rojas-Medina LM, Ley L.

    Recurrent Glioblastoma: A Review of the Treatment Options.

    Cancers . 15(17): .

    [doi:10.3390/cancers15174279]

  • Banda Sánchez C, Cubo Mateo N, Saldaña L, Valdivieso A, Earl J, González Gómez I, Rodríguez-Lorenzo LM.

    Selection and Optimization of a Bioink Based on PANC-1- Plasma/Alginate/Methylcellulose for Pancreatic Tumour Modelling.

    POLYMERS . 15(15): .

    [doi:10.3390/polym15153196]

  • Bargiela-Iparraguirre J, Herrero JM, Pajuelo-Lozano N, Perez M, Perona R, Quiroga AG, Calés C, Sanchez-Perez I.

    Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer.

    Genes & Diseases . 10(4): 1180-1182.

    [doi:10.1016/j.gendis.2023.02.025]

  • Díaz-Alejo JF, April-Monn S, Cihova M, Buocikova V, Villalón López J, Urbanova M, Lechuga CG, Tomas M, Dubovan P, Sánchez BL, Páez SC, Sanjuanbenito A, Lobo E, Romio de la Heras E, Guerra C, de la Pinta C, Barreto Melian E, Rodríguez Garrote M, Carrato A, Ruiz-Cañas L, Sainz B Jr, Torres A, Smolkova B, Earl J.

    Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue

    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS . (195): . Nº de citas: 1

    [doi:10.3791/65229]

  • Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME.

    An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.

    Pharmaceutics . 15(4): .

    [doi:10.3390/pharmaceutics15041273]

  • Frank KJ, Mulero-Sánchez A, Berninger A, Ruiz-Cañas L, Bosma A, Görgülü K, Wu N, Diakopoulos KN, Kaya-Aksoy E, Ruess DA, Kabacaoglu D, Schmidt F, Kohlmann L, van Tellingen O, Thijssen B, van de Ven M, Proost N, Kossatz S, Weber WA, Sainz B Jr, Bernards R, Algül H, Lesina M, Mainardi S.

    Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer.

    CELL REPORTS MEDICINE . 3(11): 100815-100815.

    [doi:10.1016/j.xcrm.2022.100815]

  • Cave DD, Buonaiuto S, Sainz B Jr, Fantuz M, Mangini M, Carrer A, Di Domenico A, Iavazzo TT, Andolfi G, Cortina C, Sevillano M, Heeschen C, Colonna V, Corona M, Cucciardi A, Di Guida M, Batlle E, De Luca A, Lonardo E.

    LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.

    Journal Of Experimental & Clinical Cancer Research . 41(1): 315-315. Nº de citas: 1

    [doi:10.1186/s13046-022-02516-w]

  • Alonso-Nocelo M, Ruiz-Cañas L, Sancho P, Görgülü K, Alcalá S, Pedrero C, Vallespinos M, López-Gil JC, Ochando M, García-García E, David Trabulo SM, Martinelli P, Sánchez-Tomero P, Sánchez-Palomo C, Gonzalez-Santamaría P, Yuste L, Wörmann SM, Kabacaoglu D, Earl J, Martin A, Salvador F, Valle S, Martin-Hijano L, Carrato A, Erkan M, García-Bermejo L, Hermann PC, Algül H, Moreno-Bueno G, Heeschen C, Portillo F, Cano A, Sainz B Jr.

    Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.

    Gut . 72(2): 345-359. Nº de citas: 3

    [doi:10.1136/gutjnl-2021-325564]